The long climb back to relevance continues for initial public offerings in the U.S. in 2024, as investors warm up to new publicly traded companies and IPOs are able to back that sentiment up with sturdier returns. So, where do IPOs go from here in the second half of 2024? Sustained high borrowing costs and suspense over a chaotic U.S.…
I had the opportunity to be a guest on the CapitalCosm podcast recently. Danny and I ran through the indicators that are flashing warnings that the stock market and economy are nearing the precipice of a strong downward turn. What Danny and I talked about is: What my high-level view of the market is right now. Of the eleven key…
If you don’t like these 8%, 9% and even 10%+ dividends, well, you’re not really an income investor. That’s right. As I write, select closed-end funds (CEFs) yield 10.6%. Ten. Point. Six. Per. Cent! We contrarians are locking in yields up to nearly 11%. Here’s how, broken down in an 11-step playbook for these 8%, 9%, even 10.6% yields. This…
The agriculture market is expected to experience growth due to shifting consumer preferences toward healthier and diverse diets. Moreover, rising population growth and evolving dietary habits are expected to augment the growth in the agriculture industry. Given the industry’s bright prospects, it could be wise to invest in these fundamentally strong agriculture stocks amid rising food prices. This post originally…
Shares in these three companies have all experienced a significant dip so far in 2024, lagging behind the S&P 500 index’s 14.6% gain over the same period. However, compelling evidence suggests that all three are positioned to outperform the market in the second half and beyond. Here’s why. This post originally appeared at The Motley Fool.
There are multiple reasons to consider exposure to pharmaceutical stocks for the long-term portfolio. First, pharma stocks have a low-beta and provide help in reducing the overall beta of a portfolio that’s overweight growth stocks. Further, pharma stock represents a business that’s relatively immune to economic shocks. At the same time, well established pharma companies have healthy cash flows and therefore…
The number of exchange-traded funds (ETFs) has exploded in recent years. As of this writing, the total number of index-based and actively managed ETFs, including commodity ETFs, based in the United States stood at 3,108. Total net assets of these ETFs were $8.1 trillion and accounted for 24% of assets managed by investment companies. I’ll give you three simple tips…
For a moment on June 18, the S&P 500 and Nasdaq-100 indexes had a new top holding: Nvidia Corp. (ticker: NVDA). Before paring back some gains later in the week, shares of Nvidia briefly surpassed $135 per share, giving the company a market capitalization of more than $3.3 trillion. That being said, retail investors may not find it prudent to…
Mortgage REIT stocks have strong growth prospects, driven by potential favorable market conditions, strong demand for mortgage-backed securities, and attractive dividend yields. Investors looking for exposure to the real estate and mortgage markets may find them an appealing investment option. Therefore, investors could consider buying these fundamentally strong REIT stocks with solid growth prospects. This post originally appeared at StockNews.com.
The technology sector is not closely associated with dividend payouts. Instead, it’s more closely linked with growth stocks. But this has changed somewhat in recent years. Now, many Nasdaq 100 stocks pay dividends to shareholders. And, thanks to their strong profitability and free cash flow, tech stocks can grow their dividends at a high rate each year. These three tech stocks to buy are great examples…